HIF1A and myocardial infarction: This work presents an injectable hydrogel using drug itself as crosslinking points, achieving programable release of HIF‐1α stabilizer for treating myocardial infarction (MI), and with which reports the desirable profile of myocardial HIF‐1α expression post MI.